Company Description
Sonendo, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes devices for root canal therapy in the United States and Canada.
It provides GentleWave, a tooth decay treatment, a technology platform designed for cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure.
The company also offers SoundSeal, a material used to build and create a sealing platform on the top of the crown; and Sonendo-branded liquid solution of ethylenediaminetetraacetic acid EDTA that is used to help debride and disinfect the root canal system.
In addition, it provides The Digital Office, a practice management software to enable an integrated digital office for dental practitioners.
The company was formerly known as Dentatek Corporation and changed its name to Sonendo, Inc. in March 2011.
The company was incorporated in 2006 and is headquartered in Laguna Hills, California.
| Country | Canada |
| Founded | 2006 |
| IPO Date | Oct 29, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 200 |
| CEO | Bjarne Bergheim |
Contact Details
Address: 26061 Merit Circle, Suite 101 Laguna Hills, California 92653 United States | |
| Phone | (949) 766-3636 |
| Website | sonendo.com |
Stock Details
| Ticker Symbol | SONX |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $12.00 |
| CIK Code | 0001407973 |
| CUSIP Number | 835431107 |
| ISIN Number | US8354311073 |
| Employer ID | 20-5041718 |
| SIC Code | 3843 |
Key Executives
| Name | Position |
|---|---|
| Bjarne Bergheim | President, Chief Executive Officer and Director |
| Olav B. Bergheim | Executive Director |
| Chris Guo | Interim Chief Financial Officer, Vice President of Finance and Controller |
| John P. McGaugh | Vice President of Operations |
| Bob Guyatt | Vice President of Marketing |
| Roy T. Chen | Chief Talent Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 14, 2024 | 144 | Filing |
| May 8, 2024 | 10-Q | Quarterly Report |
| May 8, 2024 | 8-K | Current Report |
| Apr 29, 2024 | ARS | Filing |
| Apr 29, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 29, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 18, 2024 | PRE 14A | Other preliminary proxy statements |
| Apr 15, 2024 | 8-K | Current Report |
| Apr 11, 2024 | 25-NSE | Filing |
| Apr 10, 2024 | 8-K | Current Report |